Tivicay PD
- Product NDC
- 49702-255
- Requested package NDC
- 49702-255-37
- 11-digit product format
- 497020255
- Labeler code
- 49702
- Product ID
- 49702-255_5037ffdb-75d0-4abb-bd21-0a1b5920042f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dolutegravir sodium
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Labeler
- ViiV Healthcare Company
- Application
- NDA213983
- Marketing category
- NDA
- Marketing start
- 2020-06-12
- Substance
- DOLUTEGRAVIR SODIUM
- Active strength
- 5 mg/1
- Pharmacologic classes
- HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N213983-001 | TIVICAY PD | DOLUTEGRAVIR SODIUM | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N213983-001 | 8129385 | 2027-10-05 | Drug substance, Drug product | 2020-06-19 | |
| N213983-001 | 8129385*PED | 2028-04-05 | Pediatric extension | ||
| N213983-001 | 9242986 | 2029-12-08 | Drug substance, Drug product | 2020-06-19 | |
| N213983-001 | 9242986*PED | 2030-06-08 | Pediatric extension |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | c0c555d07b60… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N213983-001 | TIVICAY PD | EQ 5MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2020-06-12 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N213983-001 | 8129385 | 2027-10-05 | Drug substance, Drug product | 2020-06-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N213983-001 | 8129385*PED | 2028-04-05 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N213983-001 | 9242986 | 2029-12-08 | Drug substance, Drug product | 2020-06-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N213983-001 | 9242986*PED | 2030-06-08 | Pediatric extension | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N213983-001 | 8129385 | 2027-10-05 | Drug substance, Drug product | 2020-06-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N213983-001 | 8129385*PED | 2028-04-05 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N213983-001 | 9242986 | 2029-12-08 | Drug substance, Drug product | 2020-06-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N213983-001 | 9242986*PED | 2030-06-08 | Pediatric extension | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N213983-001 | 8129385 | 2027-10-05 | Drug substance, Drug product | 2020-06-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N213983-001 | 8129385*PED | 2028-04-05 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N213983-001 | 9242986 | 2029-12-08 | Drug substance, Drug product | 2020-06-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N213983-001 | 9242986*PED | 2030-06-08 | Pediatric extension | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N213983-001 | 8129385 | 2027-10-05 | Drug substance, Drug product | 2020-06-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N213983-001 | 8129385*PED | 2028-04-05 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N213983-001 | 9242986 | 2029-12-08 | Drug substance, Drug product | 2020-06-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N213983-001 | 9242986*PED | 2030-06-08 | Pediatric extension | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N213983-001 | 8129385 | 2027-10-05 | Drug substance, Drug product | 2020-06-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N213983-001 | 8129385*PED | 2028-04-05 | Pediatric extension | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N213983-001 | 9242986 | 2029-12-08 | Drug substance, Drug product | 2020-06-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N213983-001 | 9242986*PED | 2030-06-08 | Pediatric extension | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N213983-001 | 8129385 | 2027-10-05 | Drug substance, Drug product | 2020-06-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N213983-001 | 8129385*PED | 2028-04-05 | Pediatric extension | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N213983-001 | 9242986 | 2029-12-08 | Drug substance, Drug product | 2020-06-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N213983-001 | 9242986*PED | 2030-06-08 | Pediatric extension | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N213983-001 | 8129385 | 2027-10-05 | Drug substance, Drug product | 2020-06-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N213983-001 | 8129385*PED | 2028-04-05 | Pediatric extension | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N213983-001 | 9242986 | 2029-12-08 | Drug substance, Drug product | 2020-06-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N213983-001 | 9242986*PED | 2030-06-08 | Pediatric extension | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N213983-001 | 8129385 | 2027-10-05 | Drug substance, Drug product | 2020-06-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N213983-001 | 8129385*PED | 2028-04-05 | Pediatric extension | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N213983-001 | 9242986 | 2029-12-08 | Drug substance, Drug product | 2020-06-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N213983-001 | 9242986*PED | 2030-06-08 | Pediatric extension | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N213983-001 | 8129385 | 2027-10-05 | Drug substance, Drug product | 2020-06-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N213983-001 | 8129385*PED | 2028-04-05 | Pediatric extension | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N213983-001 | 9242986 | 2029-12-08 | Drug substance, Drug product | 2020-06-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N213983-001 | 9242986*PED | 2030-06-08 | Pediatric extension | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N213983-001 | 8129385 | 2027-10-05 | Drug substance, Drug product | 2020-06-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N213983-001 | 8129385*PED | 2028-04-05 | Pediatric extension | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N213983-001 | 9242986 | 2029-12-08 | Drug substance, Drug product | 2020-06-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N213983-001 | 9242986*PED | 2030-06-08 | Pediatric extension | 5bbf6a4d5a75… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tivicay PD
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOLUTEGRAVIR SODIUM | 5 mg/1 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 3832141c-c294-474a-9473-1052c891450e | Product name | 2 | 20230105 |
| 3644e9cf-6f4d-4b63-b875-6a4b5187c47e | Product name | 1 | 20190703 |
| 44633898-5724-4273-abcc-3541a1107946 | Product name | 1 | 20180124 |
| 7d3f81af-5024-0cff-2664-d433b7688444 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49702-255-37 | Tivicay PD | 60 in 1 BOTTLE | TABLET, FOR SUSPENSION | 60 | 31 | |
| 49702-255-37 | Tivicay PD | 1 in 1 CARTON | TABLET, FOR SUSPENSION | 1 | 31 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49702-255-37 | EA - Each | 49702-255 | fbbbc9ca-1048-4228-999d-225e0ab6fb82 | 1 | 2020-07-13 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49702-255 | TIVICAY PD (DOLUTEGRAVIR SODIUM) TABLET, FOR SUSPENSION TIVICAY (DOLUTEGRAVIR SODIUM) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 29 | Current NDC, Legacy NDC, 2 package rows | 20240907_63df5af3-b8ac-4e76-9830-2dbb340af922.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1796077 | dolutegravir 10 MG Oral Tablet | PSN | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1796081 | dolutegravir 25 MG Oral Tablet | PSN | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 2374562 | dolutegravir 5 MG Tablet for Oral Suspension | PSN | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1433873 | dolutegravir 50 MG Oral Tablet | PSN | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1796079 | Tivicay 10 MG Oral Tablet | PSN | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1796083 | Tivicay 25 MG Oral Tablet | PSN | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1433879 | Tivicay 50 MG Oral Tablet | PSN | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 2374566 | Tivicay PD 5 MG Tablet for Oral Suspension | PSN | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1796079 | dolutegravir 10 MG Oral Tablet [Tivicay] | SBD | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1796083 | dolutegravir 25 MG Oral Tablet [Tivicay] | SBD | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 2374566 | dolutegravir 5 MG Tablet for Oral Suspension [Tivicay] | SBD | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1433879 | dolutegravir 50 MG Oral Tablet [Tivicay] | SBD | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1796077 | dolutegravir 10 MG Oral Tablet | SCD | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1796081 | dolutegravir 25 MG Oral Tablet | SCD | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 2374562 | dolutegravir 5 MG Tablet for Oral Suspension | SCD | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1433873 | dolutegravir 50 MG Oral Tablet | SCD | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1796077 | dolutegravir 10 MG (as dolutegravir sodium) Oral Tablet | SY | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1796081 | dolutegravir 25 MG (as dolutegravir sodium) Oral Tablet | SY | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 2374562 | dolutegravir 5 MG (as dolutegravir sodium) Tablet for Oral Suspension | SY | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1433873 | dolutegravir 50 MG (as dolutegravir sodium 52.6 MG) Oral Tablet | SY | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1796079 | Tivicay 10 MG (as dolutegravir sodium) Oral Tablet | SY | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1796083 | Tivicay 25 MG (as dolutegravir sodium) Oral Tablet | SY | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1433879 | Tivicay 50 MG (as dolutegravir sodium) Oral Tablet | SY | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 1433879 | Tivicay 50 MG Oral Tablet | SY | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 2374566 | Tivicay PD 5 MG (as dolutegravir sodium) Tablet for Oral Suspension | SY | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
| 2374566 | Tivicay PD 5 MG Tablet for Oral Suspension | SY | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 31 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 49702-255-37 | 49702025537 | 1 BOTTLE in 1 CARTON (49702-255-37) / 60 TABLET, FOR SUSPENSION in 1 BOTTLE | 1 bottle | 2020-06-12 | 0000-00-00 | No | No | Current |